---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-081684"
form_type: "8-K"
ticker: "LQDA"
cik: "0001819576"
company_name: "Liquidia Corp"
filed_at: "2023-07-17T23:59:59+00:00"
generated_at: "2026-06-13T07:51:30.088390+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Liquidia enters amended supply agreement with Lonza for YUTREPIA; increased minimum commitments, FDA timeline triggers

## Summary
- Amended Commercial Manufacturing Services and Supply Agreement with Lonza Tampa for encapsulation/packaging of YUTREPIA (treprostinil) inhalation powder.
- Initial term of 5 years from FDA regulatory approval; Lonza may terminate if FDA does not approve by December 31, 2024.
- Minimum annual order quantities materially increased compared to prior agreement; company may adjust after 13 months post-approval.
- Upon termination for FDA rejection or delay, Liquidia reimburses 50% of Lonza capital equipment costs, cap $2.5 million.
- Company delivers bulk treprostinil powder; Lonza provides encapsulation and storage services as sole supplier.

## SEC filing metadata
- accession: 0001104659-23-081684
- form_type: 8-K
- ticker: LQDA
- cik: 0001819576
- company_name: Liquidia Corp
- filed_at: 2023-07-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819576/000110465923081684/0001104659-23-081684-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819576/000110465923081684/tm2321455d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-081684
- JSON: https://secwatch.observer/filing/0001104659-23-081684.json
- Plain text: https://secwatch.observer/filing/0001104659-23-081684.txt

## Key facts
- Material Agreements
  Liquidia Corp amended Amended and Restated Commercial Manufacturing Services and Supply Agreement with Lonza Tampa LLC f/k/a Xcelience LLC (effective 2023-07-14).
  - Action: amendment
  - Agreement: supply
  - Counterparty: Lonza Tampa LLC f/k/a Xcelience LLC
  - Effective: 2023-07-14
  source text: On July 14, 2023, Liquidia Corporation, a Delaware corporation through Liquidia Technologies, Inc., a Delaware corporation (the “Company”) and wholly owned subsidiary of Liquidia Corporation, entered into an Amended and Restated Commercial Manufacturing Services and Supply Agreement (the “Agreement”) with Lonza Tampa LLC f/k/a Xcelience LLC (“Lonza”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819576/000110465923081684/0001104659-23-081684-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.